[go: up one dir, main page]

McMillen, 1995 - Google Patents

Characterization of the immune response to vaccination of racing greyhounds

McMillen, 1995

Document ID
116337727093533652
Author
McMillen G
Publication year

External Links

Snippet

Parvoviral enteritis continues to cause financial losses for commercial greyhound kennel owners and, as a result, multiple vaccinations are administered to young dogs in an attempt to enhance disease protection. In order to evaluate greyhound vaccination protocols in a …
Continue reading at search.proquest.com (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55522Cytokines; Lymphokines; Interferons
    • A61K2039/55527Interleukins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/245Herpetoviridae, e.g. herpes simplex virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53DNA (RNA) vaccination
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Similar Documents

Publication Publication Date Title
Ikemori et al. Passive protection of neonatal calves against bovine coronavirus-induced diarrhea by administration of egg yolk or colostrum antibody powder
KR101099883B1 (en) How to administer the vaccine
De Smit et al. Duration of the protection of an E2 subunit marker vaccine against classical swine fever after a single vaccination
Saif et al. Immunity to transmissible gastroenteritis virus and porcine respiratory coronavirus infections in swine
JP2655876B2 (en) Canine Coronavirus Vaccine
Haesebrouck et al. Effect of intratracheal challenge of fattening pigs previously immunised with an inactivated influenza H1N1 vaccine
KRUGER et al. Glycoproteins gI and gE of Feline Herpesvirus-1 Are Virulence Genes: Safety and Efficacy of a gI–gE− Deletion Mutant in the Natural Host
Chandrasekaran et al. Characterization of immune response and duration of protection in buffaloes immunized with haemorrhagic septicaemia vaccines
Oldham et al. In vivo role of lymphocyte subpopulations in the control of virus excretion and mucosal antibody responses of cattle infected with rotavirus
Fairbanks et al. Evaluation of a modified live virus type-1a bovine viral diarrhea virus vaccine (Singer strain) against a type-2 (strain 890) challenge
WO2020104640A1 (en) A vaccine for protection against streptococcus suis
US5916570A (en) Multivalent bovine coronavirus vaccine and method of treating bovine coronavirus infection
Hodgins et al. Serologic responses of young colostrum fed dairy calves to antigens of Pasteurella haemolytica A1
JPH08502253A (en) Method for enhancing cell-mediated immune response
McMillen Characterization of the immune response to vaccination of racing greyhounds
Erickson et al. Comparative efficacy of modified-live and inactivated vaccines in boosting disease-sparing responses to bovine viral diarrhea virus challenge in neonatally mucosally primed weanling beef calves
JP2608935B2 (en) Vaccines that protect cats against feline infectious peritonitis
Vanderpooten et al. Evaluation of parenteral vaccination methods with glycoproteins against Aujeszky's disease in pigs
WO2021185680A1 (en) A vaccine for protection against streptococcus suis serotype 9, sequence type 16
Gough et al. A viral subunit immunogen for porcine transmissible gastroenteritis
Odeón et al. The role of cell-mediated immunity in the pathogenesis of bluetongue virus serotype 11 in the experimental infection of vaccine/sensitized calves
Tan et al. Further studies on feline respiratory virus diseases: 1. Vaccination experiments
Poppensiek et al. Twenty-five years of progress in understanding major infectious diseases of dairy cattle
Tan Serological comparisons of feline respiratory viruses
Ortiz et al. Suppression of the humoral immune response to inactivated Newcastle disease virus by Mycoplasma meleagridis in the Turkey